PROGNOSTIC SIGNIFICANCE OF IMMUNOHISTOCHEMICAL EXPRESSION OF MGMT IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH TEMAZOLAMIDE

被引：0
|
作者：
Balasubramaniam, Anandh
Santosh, Vani
Arivazhagan, A.
Balaram, T.
Chandramouli, B. A.
Hegde, A. S.
Somasundaram, Kumaravel
Kondaiah, P.
Rao, M. R. S.
机构：
来源：
NEURO-ONCOLOGY | 2009年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：646 / 646
页数：1
相关论文
共 50 条
  • [31] Preoperative Naples prognostic score is a reliable prognostic indicator for newly diagnosed glioblastoma patients
    Li, Junhong
    Yang, Wanchun
    Yuan, Yunbo
    Zuo, Mingrong
    Li, Tengfei
    Wang, Zhihao
    Liu, Yanhui
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] Temozolomide in addition to Gliadel wafer and radiotherapy in adults with newly diagnosed glioblastoma multiforme: The impact of MGMT expression
    Rovin, Richard
    Winn, Robert
    Brown, Nicholas
    NEURO-ONCOLOGY, 2007, 9 (04) : 518 - 518
  • [33] Quantitative digital assessment of MGMT immunohistochemical expression in glioblastoma tissue
    Yukie Araki
    Masahiro Mizoguchi
    Koji Yoshimoto
    Tadahisa Shono
    Toshiyuki Amano
    Akira Nakamizo
    Satoshi O. Suzuki
    Toru Iwaki
    Tomio Sasaki
    Brain Tumor Pathology, 2011, 28 : 25 - 31
  • [34] Prognostic value of MGMT promoter status and EGFRvIII expression in glioblastoma patients.
    Montano, N.
    Banna, G. L.
    Martini, M.
    D'Alessandris, G.
    Cenci, T.
    Giuffrida, D.
    Maira, G.
    De Maria, R.
    Larocca, L.
    Paliini, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Quantitative digital assessment of MGMT immunohistochemical expression in glioblastoma tissue
    Araki, Yukie
    Mizoguchi, Masahiro
    Yoshimoto, Koji
    Shono, Tadahisa
    Amano, Toshiyuki
    Nakamizo, Akira
    Suzuki, Satoshi O.
    Iwaki, Toru
    Sasaki, Tomio
    BRAIN TUMOR PATHOLOGY, 2011, 28 (01) : 25 - 31
  • [36] Prognostic significance of MGMT methylation and expression of MGMT, P53, EGFR, MDM2 and PTEN in glioblastoma multiforme
    Limam, Sarra
    Missaoui, Nabiha
    Abdessayedl, Nihed
    Mestiri, Sarra
    Selmi, Boulbaba
    Mokni, Moncef
    Yacoubi, Mohamed Tahar
    ANNALES DE BIOLOGIE CLINIQUE, 2019, 77 (03) : 307 - 317
  • [37] Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma
    Merz, Maximilian
    Jauch, Anna
    Hielscher, Thomas
    Bochtler, Tilmann
    Schoenland, Stefan Olaf
    Seckinger, Anja
    Hose, Dirk
    Bertsch, Uta
    Neben, Kai
    Raab, Marc Steffen
    Hillengass, Jens
    Salwender, Hans
    Blau, Igor Wolfgang
    Lindemann, Hans-Walter
    Schmidt-Wolf, Ingo G. H.
    Scheid, Christof
    Haenel, Mathias
    Weisel, Katja C.
    Goldschmidt, Hartmut
    BLOOD ADVANCES, 2018, 2 (01) : 1 - 9
  • [38] Immunohistochemical analysis of O6-methylguanine-DNA methyltransferase (MGMT) protein expression as prognostic marker in glioblastoma patients treated with radiation therapy with concomitant and adjuvant Temozolomide
    Younis, Samar Galal
    Khedr, Rasha Abd El-Ghany
    El-Shorbagy, Safinaz Hamdy
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2016, 28 (01) : 23 - 30
  • [39] SEX-LINKED TUMORAL MGMT STATUS AND OUTCOMES IN NEWLY DIAGNOSED GLIOBLASTOMA
    Barnett, Addison
    Bamashmos, Anas Saeed
    Ali, Assad
    Li, Hong
    Bosler, David
    Lathia, Justin
    Yeaney, Gabrielle
    Sagar, Soumya
    Yu, Jennifer
    Murphy, Erin
    Chao, Samuel
    Suh, John
    Mohammadi, Alireza
    Stevens, Glen
    Angelov, Lilyana
    Peereboom, David
    Barnett, Gene
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2019, 21 : 145 - 145
  • [40] Anti-telomerase vaccine in patients with newly diagnosed, unmethylated MGMT glioblastoma: A phase II study
    Carpentier, Antoine F.
    Verlut, Clotilde
    Ghiringhelli, Francois
    Bronnimann, Charlotte
    Ursu, Renata
    Fumet, Jean David
    Gherga, Elisabeta
    Lefort, Felix
    Belin, Catherine
    Vernerey, Dewi
    Hervieu, Alice
    Laheurte, Caroline
    Meurisse, Aurelia
    Jacquin, Marion
    Malfroy, Marine
    Fagnoni-Legat, Christine
    Lehmann-Che, Jacqueline
    Boullerot, Laura
    Cuzzubbo, Stefania
    Adotevi, Olivier
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345